124 related articles for article (PubMed ID: 8099981)
21. A comparative assessment of proliferating cell nuclear antigen, c-myc p62, and nucleolar organizer region staining in non-Hodgkin's lymphomas: a histochemical and immunohistochemical study of 200 cases.
Korkolopoulou P; Patsouris E; Pangalis G; Tsenga A; Elemenoglou J; Thomas-Tsangli E; Spandidos D; Kittas C
Hum Pathol; 1993 Apr; 24(4):371-7. PubMed ID: 7684020
[TBL] [Abstract][Full Text] [Related]
22. Measurement of cellular proliferation in human prostate by AgNOR, PCNA, and SPF.
Sakr WA; Sarkar FH; Sreepathi P; Drozdowicz S; Crissman JD
Prostate; 1993; 22(2):147-54. PubMed ID: 7681206
[TBL] [Abstract][Full Text] [Related]
23. Correlation between PCNA expression and AgNOR dots in pituitary adenomas.
Klencki M; Kurnatowska I; Słowińska-Klencka D; Lewiński A; Pawlikowski M
Endocr Pathol; 2001; 12(2):163-9. PubMed ID: 11579682
[TBL] [Abstract][Full Text] [Related]
24. Argyrophilic nucleolar organizer regions in human adrenocortical neoplasms.
Kida Y; Takano Y; Okudaira M
J Cancer Res Clin Oncol; 1992; 119(1):49-54. PubMed ID: 1400566
[TBL] [Abstract][Full Text] [Related]
25. [Theory and application of silver staining of nucleolus organizer regions (AgNOR)].
Rüschoff J; Barth P
Pathologe; 1992 Feb; 13(1):13-9. PubMed ID: 1570277
[No Abstract] [Full Text] [Related]
26. Quantity of AgNORs in gastric endocrine carcinoid tumours as a potential prognostic tool.
Giuffrè G; Mormandi F; Barresi V; Bordi C; Tuccari G; Barresi G
Eur J Histochem; 2006; 50(1):45-50. PubMed ID: 16584984
[TBL] [Abstract][Full Text] [Related]
27. Nucleolar organizer regions in myogenic stromal tumours of the stomach.
Sinn HP; Lehnert T; Kandetzki C; Waldherr R
Virchows Arch A Pathol Anat Histopathol; 1989; 415(4):317-21. PubMed ID: 2475965
[TBL] [Abstract][Full Text] [Related]
28. The study of AgNOR proteins in leukemias: diagnostic value and correlation to S-phase cell fraction.
Klobusická M; Babusíková O; Mesárosová A; Kusenda J; Glasová M
Neoplasma; 1996; 43(6):397-401. PubMed ID: 8996564
[TBL] [Abstract][Full Text] [Related]
29. Correlation between PCNA and AgNOR scores in non-Hodgkin's lymphomas using sequential staining technique.
Smith FG; Murray PG; Crocker J
J Clin Pathol; 1993 Jan; 46(1):28-31. PubMed ID: 8094401
[TBL] [Abstract][Full Text] [Related]
30. Standardized demonstration of silver-stained nucleolar organizer regions-associated proteins in archival oral squamous cell carcinomas and adjacent non-neoplastic mucosa.
Piffkò J; Bànkfalvi A; Ofner D; Rasch D; Joos U; Schmid KW
Mod Pathol; 1997 Feb; 10(2):98-104. PubMed ID: 9127314
[TBL] [Abstract][Full Text] [Related]
31. AgNOR staining and quantification.
Trerè D
Micron; 2000 Apr; 31(2):127-31. PubMed ID: 10588058
[TBL] [Abstract][Full Text] [Related]
32. [Clinical significance of proliferating cell nuclear antigen (PCNA) and argyrophilic nucleolar organizer region (AgNOR) in testicular tumors].
Ohyama C; Ito A; Tokuyama S; Nakazumi H; Suzuki K; Kawamura S; Sato M; Saito S; Yoshikawa K; Hoshi S
Nihon Hinyokika Gakkai Zasshi; 1995 Oct; 86(10):1543-51. PubMed ID: 7474604
[TBL] [Abstract][Full Text] [Related]
33. Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: comparison with tumour grade, mitotic index, and silver-staining nucleolar organizer region numbers.
Delahunt B; Bethwaite PB; Nacey JN; Ribas JL
J Pathol; 1993 Aug; 170(4):471-7. PubMed ID: 8105046
[TBL] [Abstract][Full Text] [Related]
34. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
[TBL] [Abstract][Full Text] [Related]
35. The AgNoR count in ulcerative colitis with and without dysplasia.
Muscarà M; Giuffrè G; Barresi G; Tuccari G
Pathology; 1997 May; 29(2):136-40. PubMed ID: 9213331
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic value of AgNOR staining in follicular cell neoplasms of the thyroid: comparison of evaluation methods and nucleolar features.
Rüschoff J; Prasser C; Cortez T; Höhne HM; Hohenberger W; Hofstädter F
Am J Surg Pathol; 1993 Dec; 17(12):1281-8. PubMed ID: 8238736
[TBL] [Abstract][Full Text] [Related]
37. [Correlation between the grade of histological malignancy and nuclear positivity using the AgNOR technique in 6 cases of isolated bone NHL].
Cosimi MF; Casagranda I; Porta C; Moroni M; Orsi R; Nastasi G
Sangre (Barc); 1992 Oct; 37(5):399-402. PubMed ID: 1293782
[TBL] [Abstract][Full Text] [Related]
38. Nucleolar organizer regions in aspirates of malignant lymphomas and benign disorders of the lymph nodes.
Xu LZ; Wang LF
Anal Quant Cytol Histol; 1992 Apr; 14(2):148-52. PubMed ID: 1590898
[TBL] [Abstract][Full Text] [Related]
39. Proliferative activity as a prognostic factor in Borrmann type 4 gastric carcinoma.
Kakeji Y; Maehara Y; Adachi Y; Baba H; Mori M; Furusawa M; Sugimachi K
Br J Cancer; 1994 Apr; 69(4):749-53. PubMed ID: 7908217
[TBL] [Abstract][Full Text] [Related]
40. Cell cycle-dependent AgNOR analysis in invasive breast cancer.
Krüger S; Stahlhut M; Müller H
Anal Quant Cytol Histol; 2000 Oct; 22(5):358-63. PubMed ID: 11064811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]